Renal transplantation in the modern immunosuppressive era in Spain: Four-year results from a multicenter database focus on post-transplant cardiovascular disease

Kidney International

Volumn 74, Issue SUPPL. 111, 2008, Pages

  Morales, Jose M ^a   Marcén, Roberto ^b   Andrés, Amado ^a   Molina, Miguel González ^c   Castillo, Domingo Del ^d   Cabello, Mercedes ^c   Capdevila, Luis ^e   Campistol, Josep M ^f   Oppenheimer, Federico ^f   Serón, Daniel ^g   Vernet, Salvador Gil ^g   Lampreave, Ildefonso ^h   Valdés, Francisco ⁱ   Anaya, Fernando ^j   Escuín, Fernando ^k   Arias, Manuel ^l   Pallardó, Luis ^m   Bustamante, Jesús ⁿ  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^b HOSPITAL RAMÓN Y CAJAL   (Spain)

^c HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^d HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^e HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^f HOSPITAL CLÍNIC   (Spain)

^g HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^h HOSPITAL DE CRUCES   (Spain)

ⁱ HOSPITAL JUAN CANALEJO   (Spain)

^j HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^k HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^l HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^m HOSPITAL UNIVERSITARIO DR PESET   (Spain)

ⁿ HOSPITAL CLÍNICO UNIVERSITARIO DE VALLADOLID   (Spain)

more..

Author keywords

Cardiovascular disease; Graft loss; Ischemic heart disease; Mortality; Renal function; Renal transplantation

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; CREATININE; CYCLOSPORIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERLEUKIN 12 ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY; DRUG DERIVATIVE; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID;

ACUTE KIDNEY TUBULE NECROSIS; ADULT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAUSE OF DEATH; CLINICAL TRIAL; COMORBIDITY; CONFERENCE PAPER; CREATININE BLOOD LEVEL; DATA BASE; DIALYSIS; DONOR; FEMALE; FOLLOW UP; GRAFT FAILURE; GRAFT SURVIVAL; HOSPITAL ADMISSION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; ISCHEMIC HEART DISEASE; KIDNEY FUNCTION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECIPIENT; RISK FACTOR; SPAIN; SURVIVAL; SYSTOLIC BLOOD PRESSURE; ARTICLE; GRAFT REJECTION; IMMUNOLOGY; KAPLAN MEIER METHOD; KIDNEY DISEASE; LONGITUDINAL STUDY; MIDDLE AGED;

ADULT; CARDIOVASCULAR DISEASES; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KAPLAN-MEIERS ESTIMATE; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; PROSPECTIVE STUDIES; RISK FACTORS; SPAIN; TACROLIMUS;

EID: 61549139778     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2008.547     Document Type: Conference Paper

References (18)

1. Abbud-Filho M, Adams PL, Alberu J et al. A report of the Lisbon conference on the care of the kidney transplant recipient. Transplantation 2007; 83(Suppl 8): S1-S22.
2. Foley RN, Parfrey PS, Samak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 1998; 32(Suppl 3): 112-119.
3. Pascual M, Theruvath T, Tatsuo K et al. Medical progress: strategies to improve long-term outcomes after renal transplantation. N Engl J Med 2002; 346: 580.
4. Seron D, Arias M, Campistol JM, et al., for the Spanish Chronic Allograft Study Group. Late renal allograft failure between 1990 and 1998 in Spain: a changing scenario. Transplantation 2003; 76: 1588-1594.
5. Ekberg HM, Tedesco-Silva H, Demirbas A et al. Reduced exposure to calcineurin inhibitors in renal transplantation. N Engl J Med 2007; 357: 2562-2575.
6. Ojo AO, Meier-Kriesche HU, Hanson JA et al. Mycophenolate mofetil reduces late renal allograft loss independent of acute rejection. Transplantation 2000; 69: 2405-2409.
7. Kim SJ, Schaubel DE, Fenton SSA et al. Mortality after kidney transplantation: a comparison between the United States and Canada. Am J Transplant 2006; 6: 109-114.
8. Lindholm A, Albrechtsen D, Frodin L et al. Ischemic heart disease: major cause of death and graft loss alter renal transplantation. Transplantation 1995; 60: 451-457.
9. Schaefer HM, Kaplan B, Helderman JH. Mortality after kidney transplantation: what lessons can we learn from regional and country variation? Am J Transplant 2006; 6: 3-4.
10. Marcen R, Morales JM, Arias M et al. Ischemic heart disease after renal transplantation in patients on cyclosporine in Spain. J Am Soc Nephrol 2006; 17(Suppl 3): S286-S290.
11. Kasiske BL, MacLean JR, Snyder JJ. Acute myocardial infarction and kidney transplantation. J Am Soc Nephrol 2006; 17: 900-907.
12. Holdaas H, Fellstrom B, Jardine AG et al. Beneficial effect of early initiation of lipid-lowering therapy following renal transplantation. Nephrol Dial Transplant 2005; 20: 974-978.
13. Bommer WJ. Use of angiotensin-converting enzyme inhibitor/ angiotension II receptor blocker therapy to reduce cardiovascular events in high-risk patient: Part 1. Prev Cardiol 2008; 11: 148-154.
14. Meier Kriesche HU, Baliga R, Kaplan B. Decreased renal function is a strong risk factor for cardiovascular death after renal transplantation. Transplantation 2003; 75: 1291-1295.
15. Fernandez Fresnedo G, Plaza JJ, Sanchez-Plumed J et al. Proteinuria: a new marker of long-term graft and patient survival in kidney transplantation. Nephrol Dial Transplant 2004; 19(Suppl 3): 47-51.
16. Morales JM, Dominguez-Gil B. Impact of Tacrolimus and Mycophenolate Mofetil combination on cardiovascular risk profile after kidney transplantation. J Am Soc Nephrol 2006; 17(Suppl 3): s296-s303.
17. European Best Practice Guidelines for renal transplantation. Nephrol Dial Transplant 2000; 17(Suppl 4): 1-60.
18. Lentine KL, Schnitzler MA, Brennan DC et al. Cardiac evaluation before kidney transplantation: a practice patterns analysis in Medicare-insured dialysis patients. Clin J Am Soc Nephrol 2008; 3: 1115-1124.